Baculovirus-mediated expression and purification of human serum paraoxonase 1A

Journal of Lipid Research

Volumn 42, Issue 6, 2001, Pages 951-958

  Brushia, R J ^a   Forte, T M ^a   Oda, M N ^a   La Du, B N ^a   Bielicki, J K ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Antioxidant; Atherogenesis; HDL; Lipid peroxidation; Recombinant paraoxonase

Indexed keywords

2 DIETHYLAMINOETHANOL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CONCANAVALIN A; DETERGENT; GLYCAN DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LIPOXYGENASE; MANNOSE; N ACETYL BETA GLUCOSAMINIDASE; PARAOXONASE 1A; RECOMBINANT ENZYME; SEPHAROSE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; BACULOVIRUS; CHROMATOGRAPHY; CULTURE MEDIUM; DEGLYCOSYLATION; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME PURIFICATION; ENZYME SYNTHESIS; INSECT; KINETICS; LIPID PEROXIDATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; VIRUS RECOMBINANT;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BACULOVIRIDAE; BLOTTING, WESTERN; CALCIUM; CARBOXYLIC ESTER HYDROLASES; CELL LINE; CHROMATOGRAPHY; CHROMATOGRAPHY, AGAROSE; CONCANAVALIN A; DETERGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTERASES; GLYCOSIDE HYDROLASES; HUMANS; INSECTS; KINETICS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0034978852     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Human serum paraoxonase/arylesterase
2. Studies on human serum paraoxonase/arlesterase
3. Human serum paraoxonase
4. Paraoxonase and coronary heart disease
5. Paraoxonase genes and disease
6. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
7. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
8. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible oxidative role for paraoxonase
9. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
10. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
11. Purification of human serum paraoxonase/arylesterase
12. Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase
13. Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity
14. Human serum paraoxonase is inhibited in EDTA plasma
15. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R
16. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
17. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes
18. The human serum paraoxonase/arylesterase polymorphism
19. Human serum paraoxonase (PON1): Identification of essential amino acid residues by group-selective labelling and site-directed mutagenesis
20. Tryptophan residue(s) as major components of the human serum paraoxonase active site
21. Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities
22. Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase
23. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase
24. Comparison of purified human and rabbit serum paraoxonases
25. Protein measurement with the Folin phenol reagent
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedures and some applications
28. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity
29. Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
30. Phospholipid hydroperoxide glutathione peroxidase activity in tissues of rats of different age and comparison with other glutathione peroxidase
31. Modifying secretion and posttranslational processing in insect cells